Vaccines and medicines against COVID-19

Read about the current studies and development of vaccines and medicines for treatment of COVID-19, and how medicines can be approved much quicker in extraordinary situations, if patient safety is sufficiently assured.

Go to theme

Evidence: How to evaluate the efficacy of medicines

To determine whether a drug or vaccine works against a given disease, the concept of evidence is used. But what does that mean and how do you evaluate evidence?

Go to theme
indgangsikon nr 1

General public

Here you can read about reimbursement, drugs affecting the ability to drive and other topics relevant for the general public.

indgangsikon nr 2


Information on licensing, inspections, fees, company authorisations, clinical trials and more.

indgangsikon nr 3

Healthcare professionals

This section gathers information for doctors, nurses, pharmacies, dentists and other healthcare professionals.


New data analysis: Ibuprofen does not worsen COVID-19 infection

09 September 2020

The use of ibuprofen and other pain-relieving and anti-inflammatory drugs, the so-called NSAIDs, is not associated with mortality or worsening of symptoms in patients infected with coronavirus contrary to the concerns reported by some media and social media back in March.

Emergency stocks of medicines to prevent supply problems during COVID-19

02 September 2020

COVID-19 drug preparedness rules extended for the rest of the year

02 September 2020

Relaxation: Information on face masks permitted to be in Swedish, Norwegian or English besides Danish

01 January 0001